Do [11C]choline PET/CT scan data change clinical decision-making?

The practical value of any type of diagnostic and prognostic technology can only really be assessed in the context of whether the data generated by that technology change the way that physicians treat (or make recommendations about treatment for) individual patients. … READ MORE …

Detection of sites of prostate cancer recurrence after first-line EBRT

A newly published report from a group of Italian researchers provides us with some further data on the accuracy of [11C]choline PET/CT scanning in the detection of recurrent prostate cancer — in this case in men who recur after first-line external beam radiation therapy (EBRT). … READ MORE …

Newer radio-tracer shows potential in imaging of recurrent prostate cancer

Data have been emerging for a while to suggest that a new imaging agent known as anti-3-[18F]FACBC (when used in PET/CT scans may be better than [11C]choline in the identification of recurrent (or primary) cancers on PET/CT scans or than older agents like [111In]capromab pendetide (Prostascint) when used in SPECT/CT scans. … READ MORE …

The accuracy of [11C]choline PET/CT scans in actual clinical practice

Although [11C]choline PET scans have been a “hot” developing tool for the identification of sites of recurrence of prostate cancer after first-line treatment, we have few data as yet confirming the accuracy of these scans through pathology. … READ MORE …

PET/MRI vs. PET/CT in restaging of recurrent prostate cancer

A study presented this week at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Vancouver compares [11C]choline-enhanced PET/CT and PET/MRI scanning in men with recurrent prostate cancer. … READ MORE …

A clear limit to the utility of [11C]choline PET/CT scanning

 A recently reported study by a group of German researchers has indicated that [11C]choline PET/CT scanning is not sufficently accurate to be able to identify, localize, and target areas of cancerous tissue within the prostate of a man known to have prostate cancer. … READ MORE …

Prognostic application of [11C]choline PET/CT scanning in selected patients

A new commentary on the Health Imaging web site discusses recent Italian data on the potential use of [11C]choline PET/CT scanning in early re-staging and salvage treatment of men with a rising PSA after radical prostatectomy. … READ MORE …